Moreover, interleukin‐25 (IL‐25) has emerged as a critical factor in HCC progression, selectively activating macrophages within the TME to secrete CXCL10, further stimulating the EMT pathway and driving tumor growth and metastasis. This evidence concerns the gene CXCL10 and hepatocellular carcinoma.